Pediatr. praxi. 2022;23(3):188-191 | DOI: 10.36290/ped.2022.041

Chickenpox - do vaccinate or do not vaccinate?

Mgr. Petra Macounová, Bc. Adéla Staňková, doc. MUDr. Rastislav Maďar, PhD., MBA, FRCPS
Ústav epidemiologie a ochrany veřejného zdraví, Lékařská fakulta, Ostravská univerzita, Ostrava

Chickenpox, also known as varicella is an infectious disease caused by the varicella zoster virus. The infection most often occurs in childhood, without complications and ends by spontaneous recovery. However, serious and life-threatening complications can occur, especially in immunosuppressed individuals. Even if the infection is mild, this neurotropic virus remains in the nerve ganglia and may reactivate in the form of herpes zoster later. Even this clinical manifestation can be accompanied by very unpleasant complications. There is an effective vaccine against chickenpox, which is part of national immunization plans in many countries, but is not widely used in the Czech Republic. So, is it better to let the children suffer from the disease or to be vaccinated? This article summarizes current knowledge about the non/benefits of vaccination.

Keywords: chickenpox, varicella, epidemiology, prevention, vaccination.

Published: June 10, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Macounová P, Staňková A, Maďar FRCPS R. Chickenpox - do vaccinate or do not vaccinate? Pediatr. praxi. 2022;23(3):188-191. doi: 10.36290/ped.2022.041.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Beneš J. Infekční lékařství. Praha: Galén; 2009. In: kapitola C.1.17.2. Varicela (plané neštovice) a herpes zoster (pásový opar)., p. 180-183.
    2. Roháčová H. Plané neštovice a jejich možné komplikace. Med. praxi [Internet]. 2016;13(2):58-60 [cit. 2021-01-17]. Available from: DOI:10.36290/med.2016.011. Go to original source...
    3. Boštíková V, Salavec M, Smetana J, et al. Infekce vyvolané lidskými alfa herpetickými viry. Epidemiologie, mikrobiologie, imunologie [Internet]; Praha. 2014;63(3):205-212 [cit. 2021-01-16]. Available from: DOI:25412485.
    4. Havlík J. Infekční nemoci. Praha: Galén; 2002. In: kapitola 6.1.6. Plané neštovice a pásový opar., p. 129-131.
    5. Göpfertová D, Pazdiora P, Dáňová J. Epidemiologie: obecná a speciální epidemiologie infekčních nemocí. Praha: Karolinum; 2013. In: kapitola 6.7 Plané neštovice, pásový opar, p. 122.
    6. Infekce v ČR - ISIN (dříve EPIDAT). In: Státní zdravotní ústav [Internet]. Praha: SZÚ; 2022 [cit. 2022-03-28]. Available from: http://www.szu.cz/publikace/data/infekce-v-cr.
    7. Tematické řady: Infekční nemoci. Ústav zdravotnických informací a statistiky ČR (ÚZIS) [Internet]. ©2020 [cit. 2020-08-18]. Available from: https://www.uzis.cz/index.php?pg=vystupy--tematicke-rady&id=740.
    8. Wolff MH, Schünemann S, Schmidt A. Varicella-Zoster Virus: Molecular Biology, Pathogenesis, and Clinical Aspects [Internet]. Switzerland: Karger; 1999 [cit. 2022-01-30]. Available from: https://books.google.cz/books?id=845c9yKXRyYC≺intsec=frontcover&dq=Varicella-Zoster+Virus:+Molecular+Biology,+Pathogenesis,+and+Clinical+Aspects&hl=cs&sa=X&ved=2ahUKEwiG2LD_x8TuAhVk-SoKHX9tA1sQ6AEwAHoECAQQAg#v=onepage&q=Varicella-Zoster%20Virus%3A%20Molecular%20Biology%2C%20Pathogenesis%2C%20and%20Clinical%20Aspects&f=false.
    9. Schindler J. Mikrobiologie: pro studenty zdravotnických oborů. Praha: Grada; 2014. kapitola 7.2.2. In Varicella zoster virus, p. 132.
    10. Arvin AM. Varicella-zoster virus. Clin Microbiol Rev. 1996;9(3):361-381. Available from: DOI:10.1128/CMR.9.3.361. Go to original source... Go to PubMed...
    11. Sedláček D, Štruncová V. Virové exantémy dětského věku. Pediatr. praxi. [Internet]. 2008;9(6):364-368 [cit. 2022-02-23]. Available from: https://www.solen.cz/pdfs/ped/2008/06/03.pdf.
    12. Bechtel K, Chatterjee A, Lichenstein R. Pediatric chickenpox [Internet]. 2016 [cit. 2022-02-25]. Available from: https://emedicine.medscape.com/article/969773-overview.
    13. Válová K, Košťálová M, Lasotová N, et al. Fakultní nemocni Brno [Internet]. Brno: FNOL, 2013 [cit. 2022-02-01]. Available from: https://www.fnbrno.cz/areal-bohunice/neurologicka-klinika/dysartrie/t4497.
    14. Andary MT, Oleszek JL, Maurelus K, et al. Guillain-Barre Syndrome [Internet]. 2020 [cit. 2022-02-23]. Available from: https://emedicine.medscape.com/article/315632-overview#a2.
    15. Harničárová M, Ošlejšková H. Neurologické komplikace očkování. Neurol. praxi. [Internet]. 2016;17(3):178-183 [cit. 2022-02-23]. Available from: DOI:10.36290/neu.2016.037. Go to original source...
    16. Dražan D. Varicella. Pediatr. praxi. [Internet]. 2007;8(6):374-378 [cit. 2022-01-18]. Available from: https://www.pediatriepropraxi.cz/artkey/ped-200706-0010_Varicella.php.
    17. Law BJ. Chickenpox vaccination, not chickenpox, should be routine for Canadian children. CMAJ. 2001;164(10):1454-1455. Go to PubMed...
    18. Wutzler P, Bonanni P, Burgess M, et al. Varicella vaccination - the global experience. Expert Rev Vaccines. 2017;16(8):833-843. DOI:10.1080/14760584.2017.1343669. Go to original source... Go to PubMed...
    19. Coudeville L, Brunot A, Szucs TD, Dervaux B. The economic value of childhood varicella vaccination in France and Germany. Value Health. 2005;8(3):209-222. DOI:10.1111/j.1524-4733.2005.04005.x. Go to original source... Go to PubMed...
    20. Pawaskar M, Méroc E, Samant S, et al. Economic burden of varicella in Europe in the absence of universal varicella vaccination. BMC Public Health. 2021;21(1):2312. Published 2021 Dec 21. DOI:10.1186/s12889-021-12343-x. Go to original source... Go to PubMed...
    21. Horváth A. Acceptance of varicella vaccination. Hum Vaccin Immunother. 2021;17(6):1699-1702. DOI:10.1080/21645515.2020.1843337. Go to original source... Go to PubMed...
    22. Varela FH, Pinto LA, Scotta MC. Global impact of varicella vaccination programs. Hum Vaccin Immunother. 2019;15(3):645-657. DOI:10.1080/21645515.2018.1546525. Go to original source... Go to PubMed...
    23. Wutzler P, Casabona G, Cnops J, Akpo EIH, Safadi MAP. Herpes zoster in the context of varicella vaccination - An equation with several variables. Vaccine. 2018;36(46):7072-7082. DOI:10.1016/j.vaccine.2018.09.013. Go to original source... Go to PubMed...
    24. Rafferty E, Reifferscheid L, Russell ML, Booth S, Svenson LW, MacDonald SE. The impact of varicella vaccination on paediatric herpes zoster epidemiology: a Canadian population-based retrospective cohort study. Eur J Clin Microbiol Infect Dis. 2021;40(11):2363-2370. DOI:10.1007/s10096-021-04298-z. Go to original source... Go to PubMed...
    25. ZOSTAVAX. SÚKL [Internet]. [cit. 2022-04-02]. Available from: https://www.sukl.cz/modules/medication/detail.php?code=0026166&tab=info.
    26. SHINGRIX. SÚKL [Internet]. [cit. 2022-04-02]. Available from: https://www.sukl.cz/modules/medication/detail.php?kod=0222844.
    27. Wolff E, Widgren K, Scalia Tomba G, Roth A, Lep T, Andersson S. Cost-effectiveness of varicella and herpes zoster vaccination in Sweden: An economic evaluation using a dynamic transmission model. PLoS One. 2021;16(5):e0251644. Published 2021 May 13. DOI:10.1371/journal.pone.0251644. Go to original source... Go to PubMed...
    28. Česko, 2006. Vyhláška č. 537/2006 Sb.: Vyhláška o očkování proti infekčním nemocem.
    29. PRIORIX-TETRA INJ. STŘÍKAČKA. SÚKL [Internet]. [cit. 2022-04-02]. Available from: https://www.sukl.cz/modules/medication/detail.php?code=0118615&tab=info.
    30. PROQUAD. SÚKL [Internet]. [cit. 2022-04-02]. Available from: https://www.sukl.cz/modules/medication/detail.php?kod=0026114.
    31. VARILRIX. SÚKL [Internet]. [cit. 2022-04-02]. Available from: https://www.sukl.cz/modules/medication/detail.php?kod=0010277.

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.